Arginine metabolism: a potential target in pancreatic cancer therapy

Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an extremely low survival rate of <9% in the United States. As a new hallmark of cancer, metabolism reprogramming exerts crucial impacts on PDAC development and progression. Notably, arginine metabolism is altere...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jin-Shou, Wang, Cheng-Cheng, Qiu, Jiang-Dong, Ren, Bo, You, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862822/
https://www.ncbi.nlm.nih.gov/pubmed/33395072
http://dx.doi.org/10.1097/CM9.0000000000001216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862822/
https://www.ncbi.nlm.nih.gov/pubmed/33395072
http://dx.doi.org/10.1097/CM9.0000000000001216

Ejemplares similares